Cogstate Ltd
Company Profile
Business description
Cogstate Ltd is engaged in the creation, validation, and commercialisation of digital brain health assessments and the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its solutions include Digital Cognitive Assessment, Endpoint Data Quality, Remote Assessment and Healthcare Cognitive Screening. Its operating segments are Clinical Trials, Healthcare, and Administration, with Clinical Trials generating maximum revenue. The Group provides licensed software to Clinical Trials and Healthcare customers, comprising access to the software.
Contact
367 Collins Street
Level 32
MelbourneVIC3000
AUST: +61 396641300
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
Employees
249
Stocks News & Analysis
stocks
Nvidia earns upgrade as AI buildouts accelerate
stocks
Weekly earnings wrap: FMG, WDS, COL and more
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,266.50 | 5.10 | 0.06% |
| CAC 40 | 8,319.87 | 142.52 | -1.68% |
| DAX 40 | 26,367.24 | 81.28 | 0.31% |
| Dow JONES (US) | 53,569.44 | 105.56 | 0.20% |
| FTSE 100 | 10,792.54 | 85.58 | -0.79% |
| HKSE | 25,612.39 | 46.65 | 0.18% |
| NASDAQ | 26,541.35 | 411.15 | 1.57% |
| Nikkei 225 | 66,682.88 | 550.91 | 0.83% |
| NZX 50 Index | 13,853.61 | 26.44 | -0.19% |
| S&P 500 | 7,730.99 | 55.29 | 0.72% |
| S&P/ASX 200 | 9,063.50 | 12.20 | 0.13% |
| SSE Composite Index | 3,958.60 | 2.03 | 0.05% |